What is Citius Oncology, Inc.'s change in inventories?

Citius Oncology, Inc. (CTOR) reported change in inventories of $20.25K in Q1 2026.

How has Citius Oncology, Inc.'s change in inventories changed year-over-year?

Citius Oncology, Inc.'s change in inventories decreased by 97.9% year-over-year, from $957.88K to $20.25K.

What does change in inventories mean?

Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.

Citius Oncology, Inc. CTOR Change in Inventories

Change in Inventories at other companies

Merck & Co.MRK

$295M+41.3%

Delcath SystemsDCTH

-$444K-323%

Iovance Biotherapeutics, Inc.IOVA

$4.93M-64.4%

ImmunityBio, Inc.IBRX

$4.99M+2,798%

Gilead SciencesGILD

$52M-76.7%

United TherapeuticsUTHR

$40.1M+258%

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s change in inventories?: Citius Oncology, Inc. (CTOR) reported change in inventories of $20.25K in Q1 2026.
How has Citius Oncology, Inc.'s change in inventories changed year-over-year?: Citius Oncology, Inc.'s change in inventories decreased by 97.9% year-over-year, from $957.88K to $20.25K.
What does change in inventories mean?: Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.